Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • VARGATEF ® - Carcinoma, Renal Cell
    Clinical Study Number 1199.26
    Study Indication Carcinoma, Renal Cell
    Product VARGATEF ®
    Generic Name Nintedanib
    Lab Code
    Clinical Phase II
    Study Title

    A randomised, open-label, parallel-group Phase II study comparing the efficacy and tolerability of BIBF 1120 versus sunitinib in previously untreated patients with renal cell cancer

    Study Document
    Trial synopsis 1199.26 english